Education
About Us
Working with TipRanks
Follow Us
Daxor Corporation (DE:DX5)
NASDAQ:DX5
DX5 Stock Chart & Stats
€10.90
€0.30(4.11%)
At close: 4:00 PM EST
€10.90
€0.30(4.11%)
Day’s Range― - ―
52-Week Range€6.20 - €12.60
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
N/A
Enterprise Value€49.06M
Total Cash (Recent Filing)€0.00
Total Debt (Recent Filing)€262.93K
Price to Earnings (P/E)―
Beta0.22
Next Earnings
Feb 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.06
Shares Outstanding4,962,245
10 Day Avg. Volume1
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.85
Price to Book (P/B)1.04
Price to Sales (P/S)17.48
P/FCF Ratio1.45K
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Product InnovationThe newly cleared device delivers faster, precise blood volume data and is more portable and easier to use than the previous version.
Regulatory ApprovalDaxor received 510(k) clearance from the FDA for its next-gen blood volume analyzer.
Sales GrowthDaxor's operating division delivered meaningful sales growth in the first half of the year, supported by increased utilization of single-use blood volume diagnostic kits, new account additions, and military contract revenue.
Bears Say
Daxor News
DX5 FAQ
What was Daxor Corporation’s price range in the past 12 months?
Daxor Corporation lowest stock price was €6.20 and its highest was €12.60 in the past 12 months.
What is Daxor Corporation’s market cap?
Currently, no data Available
When is Daxor Corporation’s upcoming earnings report date?
Daxor Corporation’s upcoming earnings report date is Feb 26, 2026 which is in 46 days.
How were Daxor Corporation’s earnings last quarter?
Daxor Corporation released its earnings results on Aug 21, 2025. The company reported -€0.063 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.063.
Is Daxor Corporation overvalued?
According to Wall Street analysts Daxor Corporation’s price is currently Overvalued.
Does Daxor Corporation pay dividends?
Daxor Corporation does not currently pay dividends.
What is Daxor Corporation’s EPS estimate?
Daxor Corporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Daxor Corporation have?
Daxor Corporation has 4,962,245 shares outstanding.
What happened to Daxor Corporation’s price movement after its last earnings report?
Daxor Corporation reported an EPS of -€0.063 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 2.286%.
Which hedge fund is a major shareholder of Daxor Corporation?
Currently, no hedge funds are holding shares in DE:DX5
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Daxor Corporation
Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee.
Technical Analysis
Options Prices
Currently, No data available
---